Skip to main content

February 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology

Stem-Cell Mobilization More Cost-Effective with Plerixafor
Kate Smith
Read More
Financial Toxicity Impacts Treatment Adherence
Kate Smith
Read More
American-Style Capitalism Drives Drug Development: Cancer Therapies Targeting Small Subpopulations Dictate Prices
Kate Smith
Read More
FDA Approvals
The Hematology Pipeline Is Abundant
Wayne Kuznar, Kate Smith
Read More
Value and Cost-Effectiveness Analyses Should Be Included in Reimbursement Decisions
Kate Smith
Read More
Leukemia, Oncology
Psychological Distress and Financial Burden Impact Adherence to CML Treatment
Phoebe Starr
Read More
Page 3 of 3
Results 21 - 26 of 26